These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 8487048

  • 1. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Pullen J, Boyett J, Shuster J, Crist W, Land V, Frankel L, Iyer R, Backstrom L, van Eys J, Harris M.
    J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048
    [Abstract] [Full Text] [Related]

  • 2. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W, Shuster J, Look T, Borowitz M, Behm F, Bowman P, Frankel L, Pullen J, Krance R, Steuber P.
    Leukemia; 1992 May; 6 Suppl 2():162-6. PubMed ID: 1578922
    [Abstract] [Full Text] [Related]

  • 3. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J, Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer.
    J Clin Oncol; 2001 Apr 01; 19(7):1935-42. PubMed ID: 11283125
    [Abstract] [Full Text] [Related]

  • 4. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct 01; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 5. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B.
    J Clin Oncol; 1998 May 01; 16(5):1712-22. PubMed ID: 9586883
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Land VJ, Shuster JJ, Crist WM, Ravindranath Y, Harris MB, Krance RA, Pinkel D, Pullen DJ.
    J Clin Oncol; 1994 Sep 01; 12(9):1939-45. PubMed ID: 8083715
    [Abstract] [Full Text] [Related]

  • 7. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
    Sullivan MP, Chen T, Dyment PG, Hvizdala E, Steuber CP.
    Blood; 1982 Oct 01; 60(4):948-58. PubMed ID: 6956376
    [Abstract] [Full Text] [Related]

  • 8. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
    Laver JH, Barredo JC, Amylon M, Schwenn M, Kurtzberg J, Camitta BM, Pullen J, Link MP, Borowitz M, Ravindranath Y, Murphy SB, Shuster J.
    Leukemia; 2000 Mar 01; 14(3):369-73. PubMed ID: 10720128
    [Abstract] [Full Text] [Related]

  • 9. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
    Mahoney DH, Shuster J, Nitschke R, Lauer SJ, Winick N, Steuber CP, Camitta B.
    J Clin Oncol; 1998 Jan 01; 16(1):246-54. PubMed ID: 9440749
    [Abstract] [Full Text] [Related]

  • 10. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer S, Steuber CP, Camitta B.
    J Clin Oncol; 2000 Mar 01; 18(6):1285-94. PubMed ID: 10715299
    [Abstract] [Full Text] [Related]

  • 11. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM, Shuster JJ, Crist WM, Pullen DJ, Borowitz MJ, Wharam M, Patterson R, Foreman E, Vietti TJ.
    Leukemia; 1992 Jun 01; 6(6):541-6. PubMed ID: 1602793
    [Abstract] [Full Text] [Related]

  • 12. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J, Berry D, Crist W, Doering E, Fernbach D, Pullen J, Shuster J, Wharam M.
    Cancer; 1989 Jan 01; 63(1):23-9. PubMed ID: 2910421
    [Abstract] [Full Text] [Related]

  • 13. A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial.
    Lauer SJ, Shuster JJ, Mahoney DH, Winick N, Toledano S, Munoz L, Kiefer G, Pullen JD, Steuber CP, Camitta BM.
    Leukemia; 2001 Jul 01; 15(7):1038-45. PubMed ID: 11455971
    [Abstract] [Full Text] [Related]

  • 14. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA.
    Cancer; 1995 May 15; 75(10):2623-31. PubMed ID: 7736409
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul 15; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 16. Improved outcome in adult B-cell acute lymphoblastic leukemia.
    Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Löffler H, Fonatsch C, Rieder H, Heil G, Heinze B, Arnold R, Hossfeld D, Büchner T, Koch P, Freund M, Hiddemann W, Maschmeyer G, Heyll A, Aul C, Faak T, Kuse R, Ittel TH, Gramatzki M, Diedrich H, Kolbe K, Fuhr HG, Fischer K, Schadeck-Gressel C, Weiss A, Strohscheer I, Metzner B, Fabry U, Gökbuget N, Völkers B, Messerer D, Uberla K.
    Blood; 1996 Jan 15; 87(2):495-508. PubMed ID: 8555471
    [Abstract] [Full Text] [Related]

  • 17. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N, Shuster JJ, Bowman WP, Borowitz M, Farrow A, Jacaruso D, Buchanan GR, Kamen BA.
    J Clin Oncol; 1996 Oct 15; 14(10):2803-11. PubMed ID: 8874342
    [Abstract] [Full Text] [Related]

  • 18. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK.
    Cancer; 1999 Apr 15; 85(8):1859-65. PubMed ID: 10223582
    [Abstract] [Full Text] [Related]

  • 19. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia.
    Lin WY, Liu HC, Yeh TC, Wang LY, Liang DC.
    Pediatr Blood Cancer; 2008 Mar 15; 50(3):523-7. PubMed ID: 17455314
    [Abstract] [Full Text] [Related]

  • 20. Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131.
    Salzer WL, Burke MJ, Devidas M, Dai Y, Hardy KK, Kairalla JA, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, Wood B, Heerema NA, Carroll AJ, Winick N, Carroll WL, Raetz EA, Loh ML, Hunger SP.
    J Clin Oncol; 2020 Aug 10; 38(23):2628-2638. PubMed ID: 32496902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.